Kim, J. M., Weiss, S., Sinard, J. H., & Pointdujour-Lim, R. (2020). Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma. Ocul Oncol Pathol.
Chicago Style CitationKim, Jenna May, Sarah Weiss, John H. Sinard, and Renelle Pointdujour-Lim. "Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma." Ocul Oncol Pathol 2020.
MLA CitationKim, Jenna May, Sarah Weiss, John H. Sinard, and Renelle Pointdujour-Lim. "Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma." Ocul Oncol Pathol 2020.
Warning: These citations may not always be 100% accurate.